Detalles de la búsqueda
1.
Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.
Cancers (Basel)
; 15(13)2023 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444475
Resultados
1 -
1
de 1
1
Próxima >
>>